- Home
- AARD vs HMR Comparison
AARD vs HMR Comparison
Compare AARD & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- HMR
- Stock Information
- Founded
- AARD 2017
- HMR 1984
- Country
- AARD United States
- HMR Greece
- Employees
- AARD N/A
- HMR N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- HMR Marine Transportation
- Sector
- AARD Health Care
- HMR Consumer Discretionary
- Exchange
- AARD Nasdaq
- HMR Nasdaq
- Market Cap
- AARD 154.9M
- HMR 159.3M
- IPO Year
- AARD 2025
- HMR N/A
- Fundamental
- Price
- AARD $10.14
- HMR $2.74
- Analyst Decision
- AARD Strong Buy
- HMR Strong Buy
- Analyst Count
- AARD 4
- HMR 1
- Target Price
- AARD $31.50
- HMR $7.00
- AVG Volume (30 Days)
- AARD 69.4K
- HMR 151.8K
- Earning Date
- AARD 01-01-0001
- HMR 01-01-0001
- Dividend Yield
- AARD N/A
- HMR N/A
- EPS Growth
- AARD N/A
- HMR N/A
- EPS
- AARD N/A
- HMR N/A
- Revenue
- AARD N/A
- HMR $36,365,745.00
- Revenue This Year
- AARD N/A
- HMR N/A
- Revenue Next Year
- AARD N/A
- HMR N/A
- P/E Ratio
- AARD N/A
- HMR $20.33
- Revenue Growth
- AARD N/A
- HMR 662.74
- 52 Week Low
- AARD $4.88
- HMR $1.45
- 52 Week High
- AARD $19.58
- HMR $10.04
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- HMR N/A
- Support Level
- AARD N/A
- HMR N/A
- Resistance Level
- AARD N/A
- HMR N/A
- Average True Range (ATR)
- AARD 0.00
- HMR 0.00
- MACD
- AARD 0.00
- HMR 0.00
- Stochastic Oscillator
- AARD 0.00
- HMR 0.00
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. It is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management.